Zydus Pharmaceuticals (USA) Inc recalls
17 recall notices naming Zydus Pharmaceuticals (USA) Inc since January 2025, in United States. The most recent was published 21 Oct 2026.
Latest recalls (17)
- Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for InjectionFDAFailed Impurities/Degradation Specifications.
- Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release TabletsFDACGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
- Zydus Pharmaceuticals (USA) Inc recalls Erythromycin TabletsFDACGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
- Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl CapsulesFDAFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
- Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsulesFDASubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride TabletsFDAFailed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate CapsulesFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate…
- Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochlorideFDACGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…
- Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFDAFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
- Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFDAFailed Impurity/Degradation Specifications
- Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride InjectionFDAFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
- Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsFDACGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
- Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFDAFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation…
- Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral SuspensionFDAFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during…
- Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine TabletsFDAPresence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
- Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride TabletsFDACGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
- Zydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFDAFailed Impurities/Degradation Specifications